Laporan Laba Rugi (TTM)
Laporan Laba Rugi Pharma Foods International Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 10-31 |
2021 01-31 |
2021 04-30 |
2021 07-31 |
2021 10-31 |
2022 01-31 |
2022 04-30 |
2022 07-31 |
2022 10-31 |
2023 01-31 |
2023 04-30 |
2023 07-31 |
2023 10-31 |
2024 01-31 |
2024 04-30 |
2024 07-31 |
2024 10-31 |
2025 01-31 |
2025 04-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20,650 | 29,294 | 37,989 | 46,752 | 50,971 | 55,180 | 57,054 | 60,185 | 64,609 | 66,507 | 68,668 | 68,572 | 67,684 | 65,081 | 63,210 | 62,147 | 60,601 | 60,352 | 61,793 |
| Change (%) | 41.86 | 29.68 | 23.07 | 9.02 | 8.26 | 3.40 | 5.49 | 7.35 | 2.94 | 3.25 | -0.14 | -1.29 | -3.85 | -2.87 | -1.68 | -2.49 | -0.41 | 2.39 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 3,818 | 4,948 | 5,946 | 7,027 | 7,604 | 9,712 | 10,792 | 12,077 | 13,363 | 13,047 | 13,476 | 13,293 | 13,513 | 13,088 | 12,935 | 13,395 | 12,666 | 12,416 | 12,616 |
| Change (%) | 29.60 | 20.17 | 18.18 | 8.21 | 27.72 | 11.12 | 11.91 | 10.65 | -2.36 | 3.29 | -1.36 | 1.66 | -3.15 | -1.17 | 3.56 | -5.44 | -1.97 | 1.61 | |
| % of Revenue | 18.49 | 16.89 | 15.65 | 15.03 | 14.92 | 17.60 | 18.92 | 20.07 | 20.68 | 19.62 | 19.62 | 19.39 | 19.96 | 20.11 | 20.46 | 21.55 | 20.90 | 20.57 | 20.42 |
| Gross Operating Profit | 16,832 | 24,346 | 32,043 | 39,725 | 43,367 | 45,468 | 46,262 | 48,108 | 51,246 | 53,460 | 55,192 | 55,279 | 54,171 | 51,993 | 50,275 | 48,752 | 47,935 | 47,936 | 49,177 |
| Change (%) | 44.64 | 31.62 | 23.97 | 9.17 | 4.84 | 1.75 | 3.99 | 6.52 | 4.32 | 3.24 | 0.16 | -2.00 | -4.02 | -3.30 | -3.03 | -1.68 | 0.00 | 2.59 | |
| % of Revenue | 81.51 | 83.11 | 84.35 | 84.97 | 85.08 | 82.40 | 81.08 | 79.93 | 79.32 | 80.38 | 80.38 | 80.61 | 80.04 | 79.89 | 79.54 | 78.45 | 79.10 | 79.43 | 79.58 |
| SG&A | 16,179 | 21,643 | 27,909 | 33,486 | 34,076 | 37,015 | 41,601 | 46,211 | 53,051 | 54,361 | 52,449 | 50,757 | 46,776 | 44,956 | 43,987 | 42,561 | 41,409 | 42,531 | 46,252 |
| Change (%) | 33.77 | 28.95 | 19.98 | 1.76 | 8.62 | 12.39 | 11.08 | 14.80 | 2.47 | -3.52 | -3.23 | -7.84 | -3.89 | -2.16 | -3.24 | -2.71 | 2.71 | 8.75 | |
| % of Revenue | 78.35 | 73.88 | 73.47 | 71.62 | 66.85 | 67.08 | 72.92 | 76.78 | 82.11 | 81.74 | 76.38 | 74.02 | 69.11 | 69.08 | 69.59 | 68.48 | 68.33 | 70.47 | 74.85 |
| R&D | 457 | 419 | 462 | 522 | 570 | 622 | 643 | 766 | 827 | 869 | 890 | 840 | 911 | 909 | 946 | 978 | 1,038 | 1,134 | 1,233 |
| Change (%) | -8.32 | 10.26 | 12.99 | 9.20 | 9.12 | 3.38 | 19.13 | 7.96 | 5.08 | 2.42 | -5.62 | 8.45 | -0.22 | 4.07 | 3.38 | 6.13 | 9.25 | 8.73 | |
| % of Revenue | 2.21 | 1.43 | 1.22 | 1.12 | 1.12 | 1.13 | 1.13 | 1.27 | 1.28 | 1.31 | 1.30 | 1.22 | 1.35 | 1.40 | 1.50 | 1.57 | 1.71 | 1.88 | 2.00 |
| OpEx | 20,492 | 27,050 | 34,358 | 41,078 | 42,293 | 47,392 | 53,081 | 59,105 | 67,299 | 68,343 | 66,886 | 64,962 | 61,278 | 59,052 | 57,967 | 57,033 | 55,212 | 56,150 | 60,162 |
| Change (%) | 32.00 | 27.02 | 19.56 | 2.96 | 12.06 | 12.00 | 11.35 | 13.86 | 1.55 | -2.13 | -2.88 | -5.67 | -3.63 | -1.84 | -1.61 | -3.19 | 1.70 | 7.15 | |
| % of Revenue | 99.23 | 92.34 | 90.44 | 87.86 | 82.97 | 85.89 | 93.04 | 98.21 | 104.16 | 102.76 | 97.40 | 94.74 | 90.54 | 90.74 | 91.71 | 91.77 | 91.11 | 93.04 | 97.36 |
| Operating Income | 158 | 2,244 | 3,631 | 5,674 | 8,678 | 7,788 | 3,973 | 1,080 | -2,690 | -1,836 | 1,782 | 3,610 | 6,406 | 6,029 | 5,243 | 5,114 | 5,389 | 4,202 | 1,631 |
| Change (%) | 1,320.25 | 61.81 | 56.27 | 52.94 | -10.26 | -48.99 | -72.82 | -349.07 | -31.75 | -197.06 | 102.58 | 77.45 | -5.89 | -13.04 | -2.46 | 5.38 | -22.03 | -61.19 | |
| % of Revenue | 0.77 | 7.66 | 9.56 | 12.14 | 17.03 | 14.11 | 6.96 | 1.79 | -4.16 | -2.76 | 2.60 | 5.26 | 9.46 | 9.26 | 8.29 | 8.23 | 8.89 | 6.96 | 2.64 |
| Interest Expense | -9 | -10 | -11 | -12 | -12 | -20 | -21 | -26 | -42 | -36 | -45 | -48 | -44 | -52 | -55 | -62 | -72 | -76 | -86 |
| Change (%) | 11.11 | 10.00 | 9.09 | -0.00 | 66.67 | 5.00 | 23.81 | 61.54 | -14.29 | 25.00 | 6.67 | -8.33 | 18.18 | 5.77 | 12.73 | 16.13 | 5.56 | 13.16 | |
| % of Revenue | -0.04 | -0.03 | -0.03 | -0.03 | -0.02 | -0.04 | -0.04 | -0.04 | -0.07 | -0.05 | -0.07 | -0.07 | -0.07 | -0.08 | -0.09 | -0.10 | -0.12 | -0.13 | -0.14 |
| Net Income | 45 | 1,780 | 2,437 | 3,841 | 6,499 | 5,848 | 2,004 | -374 | -3,425 | -2,849 | 978 | 3,081 | 5,187 | 4,763 | 3,869 | 3,205 | 3,279 | 2,666 | 226 |
| Change (%) | 3,855.56 | 36.91 | 57.61 | 69.20 | -10.02 | -65.73 | -118.66 | 815.78 | -16.82 | -134.33 | 215.03 | 68.35 | -8.17 | -18.77 | -17.16 | 2.31 | -18.69 | -91.52 | |
| % of Revenue | 0.22 | 6.08 | 6.42 | 8.22 | 12.75 | 10.60 | 3.51 | -0.62 | -5.30 | -4.28 | 1.42 | 4.49 | 7.66 | 7.32 | 6.12 | 5.16 | 5.41 | 4.42 | 0.37 |
Source: Capital IQ
